Lifecore Biomedical, Inc. \De\

Ownership Transactions Reported by 24 Insiders

Symbol
LFCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3515 Lyman Boulevard, Chaska, MN

There are no Buy or Sell transactions made by insiders since 9/14/2023

Lifecore Biomedical, Inc. \De\ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Wynnefield Partners Small Cap Value Lp I 10%+ Owner $35.2M Jan 9, 2023
Christopher S. Kiper Director $21M Jul 8, 2024
James Hall Chief Executive Officer, Director $4.25M Jun 1, 2023
Paul Josephs Chief Executive Officer, Director $3.61M May 20, 2024
Ryan Lake Chief Financial Officer $1.84M Sep 3, 2024
Albert D. Bolles Chief Executive Officer $1.64M May 23, 2022
John Morberg Chief Financial Officer $879K Jan 18, 2024
Nelson Obus Director $831K Jul 8, 2024
Lovas Katrina Houde Director $629K Jul 8, 2024
Joshua Schechter Director $628K Jul 8, 2024
Craig A. Barbarosh Director $617K Jul 8, 2024
Jeffrey L. Edwards Director $558K Jul 8, 2024
Raymond Diradoorian Director $490K Jul 8, 2024
Tonia L. Pankopf Director $417K Jun 4, 2022
Nathaniel Calloway Director $406K Jul 8, 2024
Catherine A. Sohn Director $378K Jun 4, 2022
Timothy P. Burgess Senior VP of Supply Chain $339K Jul 27, 2021
Deborah Carosella Director $256K Jun 4, 2022
Andrew Kenneth William Powell Director $192K Jun 4, 2022
Matthew E. Korenberg Director $172K Aug 19, 2024
Paul Harold Johnson Director $172K Aug 19, 2024
Humberto C. Antunes Director $172K Aug 19, 2024
Jason Aryeh Director $172K Aug 19, 2024
Patrick D. Walsh Director $49.4K Jun 4, 2021

Recent Insider Transactions by Companies or Individuals for Lifecore Biomedical, Inc. \De\

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.